Mohammad Mushahid Khan

About

My research interest is focused on the role of de novo lipid metabolism in the psycho-pathophysiology and treatment outcome in patients with psychiatric and neurological disorders combined with animal model studies. We are using behavioural, lipidomic, proteomic and genomic approaches to achieve our objectives.

Employment

• Department of Biotechnology, Era's Lucknow Medical Ciollege and Hospital, and Faculty of Science, Era University Professor
  2021 - Present
• Medical College of Georgia, Augusta, GA, USA Postdoc (2001-2003), Res Associated (2003-2004), Assistant Research Scientist (2004-2006), Res Scientist/Assist Professor (2007-2008)
  2001 - 2008

Education

• Aligarh Muslim University MSc,PhD
  1993 - 2000

Projects & Funding

Projects & funding information is unavailable.

Publications (30)

• Childhood insulin resistance and neural stem cell dysfunction in psychiatric disorders: Role of de novo lipogenesis and treatment perspectives.
  World journal of stem cells 2025 DOI: 10.4252/wjsc.v17.i7.106194
  +Save
• Erythrocyte membrane nervonic acid in drug-naive first-episode psychosis and chronic medicated schizophrenia: Implication for impaired myelination and prognosis
  World J Psychiatry 2025
  +Save
• Metabolic complications of psychotropic medications in psychiatric disorders: Emerging role of de novo lipogenesis and therapeutic consideration.
  World journal of psychiatry 2024 DOI: 10.5498/wjp.v14.i6.767
  +Save
• Role of de novo lipogenesis in inflammation and insulin resistance in Alzheimer's disease
  International Journal of Biological Macromolecules 2023 DOI: 10.1016/j.ijbiomac.2023.124859
  +Save
• Role of de novo lipogenesis in insulin resistance in first-episode psychosis and therapeutic options
  Neuroscience & Biobehavioral Reviews 2022 DOI: 10.1016/j.neubiorev.2022.104919
  +Save
• Disrupted leptin-fatty acid biosynthesis is an early manifestation of metabolic abnormalities in schizophrenia.
  World journal of psychiatry 2022 DOI: 10.5498/wjp.v12.i6.827
  +Save
• Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic Factors.
  CNS & neurological disorders drug targets 2022 DOI: 10.2174/1871527321666220401124151
  +Save
• Translating cognitive effect of neurogenesis augmentation by antipsychotic drugs in schizophrenia: growth factors in the loop
  2022 DOI: 10.22541/au.164864975.57974483/v1
  +Save
• Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders.
  International journal of endocrinology 2018
  +Save
• Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.
  CNS drugs 2016 DOI: 10.1007/s40263-016-0343-6
  +Save